Methodist names new clinical director of hepatology at the Methodist Liver CenterHouston, TX - 6/25/2007
The Methodist Transplant Center named Dr. Joseph Galati medical director of hepatology this week.
Galati has been part of the Texas Medical Center for more than 14 years, and is known internationally for his clinical care and research in liver disease and transplant medicine.
“Joining Methodist is a great opportunity to further expand a strong program,” Galati said. “I look forward to establishing a center at Methodist that treats all facets of liver disease, stressing prevention and early diagnosis, as well as further developing liver transplantation.”
Galati’s primary point of interest is currently hepatitis C and non-alcoholic fatty liver disease, which he said is rising by epidemic proportions due to obesity, high cholesterol, diabetes and other metabolic disorders.
“We are honored to have a physician with such knowledge, skill and compassion join our team here,” said Dr. Osama Gaber, director of transplantation at Methodist. “We look forward to Dr. Galati helping lead the effort to establish one of the largest centers in the nation for management of liver disease.”
After attending medical school at St. George’s University School of Medicine, Galati completed his internship and residency in Internal Medicine at State University of New York Health Science Center in Brooklyn. He performed his fellowship training in gastroenterology, hepatology and transplant medicine at University of Nebraska Medical Center.
Galati’s research has focused on the effect of liver disease on the function of the stomach and intestines as well as viral hepatitis.